Anson Funds Management LP - 30 Jun 2025 SCHEDULE 13G/A Report for NRX PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share (NRXP)

Filing Manager: Anson Funds Management LP
Reporting Manager: Anson Funds Management LP
Security: NRX PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share
Symbol: NRXP
Shares outstanding: 17,257,796 shares
Disclosed Ownership: 1,604,975 shares
Ownership: 9.3%
Form type: SCHEDULE 13G/A
Filing time: 14 Aug 2025, 21:53:21 UTC
Date of event: 30 Jun 2025
Previous filing: 15 May 2025
SEC: View on sec.gov

Quoteable Key Fact

"Anson Funds Management LP disclosed 9.3% ownership in NRX PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share (NRXP) on 30 Jun 2025."

Quick Takeaways

Anson Funds Management LP filed SCHEDULE 13G/A for NRX PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share (NRXP).
Disclosed ownership: 9.3%.
Date of event: 30 Jun 2025.

This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
You can verify ownership claims directly against the original SEC filing.

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

Name	Ownership	Shares Owned	shared voting power	Signature	Title
Anson Funds Management LP	9.3%	1,604,975	1,604,975	/s/ Tony Moore	Tony Moore, Manager
Anson Management GP LLC	9.3%	1,604,975	1,604,975	/s/ Tony Moore	Tony Moore, Manager
Tony Moore	9.3%	1,604,975	1,604,975	/s/ Tony Moore	Tony Moore, Manager
Anson Advisors Inc.	9.3%	1,604,975	1,604,975	/s/ Amin Nathoo	Amin Nathoo, Director
Amin Nathoo	9.3%	1,604,975	1,604,975	/s/ Amin Nathoo	Amin Nathoo, Director
Moez Kassam	9.3%	1,604,975	1,604,975	/s/ Moez Kassam	Moez Kassam, Director